2019 in Review: A Flurry of Major Drug Mergers and Acquisitions

2019 was one of the biggest years on record for pharma mergers and acquisitions, including the third largest acquisition of all time — Bristol-Myers Squibb’s $74 billion acquisition of Celgene.
Source: Drug Industry Daily